- Cancer Antibodies
- Metabolism Antibodies
- New Antibodies
- Crown Antibodies
- Secondary Antibodies >
- Stem Cells
- Neurodegeneration >
- Goat Antibodies
- GPCR Antibodies
- Infectious Disease and Small Molecules
- Loading Control Antibodies
- Tag Antibody
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Biological Process >
- FL cDNA Clones
ACO2 Antibody (C-term) Blocking Peptide
United StatesOrdering Information
AlbaniaAustraliaAustriaBelgiumBosnia & HerzegovinaBrazilBulgariaCanadaChinaCroatiaCyprusCzech RepublicDenmarkEstoniaFinlandFranceGermanyGreeceHong KongHungaryIcelandIndiaIndonesiaIrelandIsraelItalyJapanKoreaLatviaLithuaniaLuxembourgMacedoniaMalaysiaMaltaNetherlandsNew ZealandNorwayPakistanPolandPortugalRomaniaSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUnited StatesVietnamOthers
|BP7561b||0.1 mg||In Stock||Call||DISCONTINUED INQUIRE CLICK INQUIRE Add to cart|
- Citations : 0
ACO2 Antibody (C-term) Blocking Peptide - Product Information
ACO2 Antibody (C-term) Blocking Peptide - Additional Information
|Gene ID 50|
Aconitate hydratase, mitochondrial, Aconitase, Citrate hydro-lyase, ACO2
The synthetic peptide sequence used to generate the antibody AP7561b was selected from the C-term region of human ACO2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
This product is for research use only. Not for use in diagnostic or therapeutic procedures.
ACO2 Antibody (C-term) Blocking Peptide - Protein Information
Catalyzes the isomerization of citrate to isocitrate via cis-aconitate.
ACO2 Antibody (C-term) Blocking Peptide - Related Products
ACO2 Antibody (C-term) Blocking Peptide - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
ACO2 belongs to the aconitase/IPM isomerase family. It is an enzyme that catalyzes the interconversion of citrate to isocitrate via cis-aconitate in the second step of the TCA cycle. It was found to be one of the mitochondrial matrix proteins that are preferentially degraded by the serine protease 15(PRSS15), also known as Lon protease, after oxidative modification.
Yu,Z.,Prostate 66 (10), 1061-1069 (2006)Tsui,K.H.,Asian J. Androl. 8 (3), 307-315 (2006)Ahmed,M.,J. Proteome Res. 4 (3), 931-940 (2005)